We are live on ! Find out more
BGA

Belmont Global Advisors Portfolio holdings

AUM $106M
1-Year Est. Return 2.89%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
–
Cap. Flow
+$117M
Cap. Flow %
94.29%
Top 10 Hldgs %
37.9%
Holding
127
New
127
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TCRT icon
Alaunos Therapeutics
TCRT
+$10.2M
2
RNET
RigNet, Inc.
RNET
+$6.16M
3
HALO icon
Halozyme
HALO
+$4.4M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$4.27M
5
EPD icon
Enterprise Products Partners
EPD
+$4.14M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Energy 39.31%
2 Healthcare 22.65%
3 Technology 6.98%
4 Communication Services 4.54%
5 Industrials 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBS icon
126
Sabesp
SBS
$18.4B
$113K 0.09%
+51,565
New +$106K
EXTR icon
127
Extreme Networks
EXTR
$3.8B
$105K 0.08%
+15,000
New +$93.2K
2 3 4 5
6

Similar funds

LOT
Lombard Odier Transatlantic Montreal, Quebec, Canada $105M AUM 10.28% 1-Year Est. Return
EC
Eachwin Capital New York $108M AUM 14.45% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.34% 1-Year Est. Return
DCMM
DG Capital Management (Massachusetts) Boston, Massachusetts $102M AUM 29.14% 1-Year Est. Return
PCM
Panning Capital Management New York $97.5M AUM 302.5% 1-Year Est. Return
SVGI
Sapphire Ventures (GPE) I Palo Alto, California $115M AUM 11.63% 1-Year Est. Return
EDRM
Edmond de Rothschild (Monaco) Monaco $116M AUM
EDRAML
Edmond de Rothschild Asset Management (Luxembourg) Luxembourg $95.2M AUM 19.45% 1-Year Est. Return

Belmont Global Advisors's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Belmont Global Advisors, which disclosed 127 positions worth $124M. Its ten largest holdings account for 38% of the portfolio.

Its largest position is Alaunos Therapeutics: 17,100 shares worth $11.1M.

By sector, the portfolio is most concentrated in Energy at 39% of assets, followed by Healthcare and Technology.

  • Belmont Global Advisors's largest Q4 2013 buy was Alaunos Therapeutics: 17,100 shares worth $11.1M.
  • Belmont Global Advisors's ten largest holdings make up 38% of its $124M portfolio in Q4 2013.
  • Belmont Global Advisors disclosed 127 positions in Q4 2013, its first 13F filing on record.

Based on Belmont Global Advisors's 13F filing for Q4 2013, filed 31 Jan 2014.